Awareness, treatment and control of dyslipidemia in middle-aged and older population in Guiyang: A three-year follow-up study

doi:10.16150/j.1671-2870.2016.05.011

Abstract

Abstract: Objective: To study the status of awareness, treatment, control of dyslipidemia in people aged40years, over in Guiyang. Methods: A total of6,872adults aged40years, over with dyslipidemia in Guiyang were recruited randomly in2011, 2014. Baseline, follow-up clinical, laboratory data were collected through questionnaire survey, physical examination, blood glucose, lipid tests. The status of awareness, treatment, control of dyslipidemia, relative factors were analyzed. Results: Three years of follow up showed that the awareness, treatment, control rates of dyslipidemia among middle-aged, older adults with dyslipidemia were29.9%, 6.4%, 17.2%, respectively, the successful control rates of HDL cholesterol, LDL cholesterol, total cholesterol, triglyceride were76.7%, 27.5%, 19.9%, 27.7%, respectively. Factors related to unsuccessful control included female, postprandial blood glucose, diastolic blood pressure, BMI. Conclusions: The awareness, treatment, successful control rates of dyslipidemia in middle-aged, over adults with dyslipidemia in Guiyang are low, should pay more attention

Key words: Dyslipidemia, Awareness rate, Treatment rate, Control rate

CLC Number:

R589.2

ZHANG Miao, ZHANG Ying, SHI Lixin, ZHANG Qiao, PENG Nianchun, HU Ying. Awareness, treatment and control of dyslipidemia in middle-aged and older population in Guiyang: A three-year follow-up study[J]. Journal of Diagnostics Concepts & Practice, 2016, 15(05): 487-491.

References

[1] Healy GN, Matthews CE, Dunstan DW, et al.Sedentary time and cardio-metabolic biomarkers in US adults: NHANES 2003-06[J]. Eur Heart J,2011,32(5):590-597.
[2] McQueen MJ, Hawken S, Wang X, et al. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries(the INTERHEART study): a case-control study[J]. Lancet,2008,372(9634):224-233.
[3] Farzadfar F, Finucane MM, Danaei G, et al.National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3·0 million participants[J]. Lancet,2011,377(9765):578-586.
[4] Kuklina EV, Yoon PW, Keenan NL.Trends in high le-vels of low-density lipoprotein cholesterol in the United States, 1999-2006[J]. JAMA,2009,302(19):2104-2110.
[5] Carroll MD, Lacher DA, Sorlie PD, et al.Trends in serum lipids and lipoproteins of adults, 1960-2002[J]. JAMA,2005,294(14):1773-1781.
[6] Downs JR, Clearfield M, Weis S, et al.Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study[J]. JAMA,1998,279(20):1615-1622.
[7] Shepherd J, Cobbe SM, Ford I, et al.Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group[J]. N Engl J Med,1995,333(20):1301-1307.
[8] 李剑虹, 王丽敏, 米生权, 等. 2010年我国成年人血脂异常知晓率和治疗率及控制率调查[J]. 中华预防医学杂志,2012,46(8):687-691.
[9] Ning G; Reaction Study Group.Risk Evaluation of cAncers in Chinese diabeTic Individuals: a lONgitudinal (REACTION) study[J]. J Diabetes,2012,4(2):172-173.
[10] 中国成人血脂异常防治指南制订联合委员会. 中国成人血脂异常防治指南[J]. 中华心血管病杂志,2007,35(5):390-413.
[11] 张巧, 时立新, 彭年春, 等. 贵阳城区糖尿病、糖尿病前期流行病学调查及危险因素分析[J]. 中华内分泌代谢杂志,2013,29(2):144-147.
[12] 李剑虹,王丽敏,李镒冲,等.2010年我国成年人血脂异常流行特点[J]. 中华预防医学杂志,2012,46(5):414-418.
[13] Stamler J, Daviglus ML, Garside DB, et al.Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity[J]. JAMA,2000,284(3):311-318.
[14] LaRosa JC, He J, Vupputuri S. EEffect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials[J]. JAMA,1999,282(24):2340-2346.
[15] Lee YH, Lee SG, Lee MH, et al.Serum cholesterol concentration and prevalence, awareness, treatment, and control of high low-density lipoprotein cholesterol in the Korea National Health and Nutrition Examination Surveys 2008-2010: Beyond the Tip of the Iceberg[J]. J Am Heart Assoc,2014,3(1):e000650.
[16] 孙永红, 刘娜. 中青年干部血脂异常知晓及治疗状况调查分析[J]. 心血管病防治知识(学术版),2012,11(2):8-9.
[17] Cai L, Zhang L, Liu A, et al.Prevalence, awareness, treatment, and control of dyslipidemia among adults in Beijing, China[J]. J Atheroscler Thromb,2012,19(2):159-168.
[18] Upadhyay UD, Waddell EN, Young S, et al.Prevalence, awareness, treatment, and control of high LDL cholesterol in New York City, 2004[J]. Prev Chronic Dis,2010,7(3):A61.
[19] He J, Gu D, Reynolds K, et al.Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China[J]. Circulation,2004,110(4):405-411.
[20] 李鹏, 李勇, 郭志刚. 中国人群血脂流行病学研究25年回顾与展望[J]. 心血管病学进展,2007,28(5):776-780.